Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone

OBJECTIVE: Within 5 years after curative surgery for stage II colon cancer 25% of patients will relapse due to minimal residual disease (MRD). MRD is the net result of the biological properties of subpopulations of primary tumour cells which enable them to disseminate, implant in distant tissues and...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Villalon, Ricardo, Orrego, Shenda, Guzman, Eghon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629478/
https://www.ncbi.nlm.nih.gov/pubmed/34452551
http://dx.doi.org/10.31557/APJCP.2021.22.8.2391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629478/
https://www.ncbi.nlm.nih.gov/pubmed/34452551
http://dx.doi.org/10.31557/APJCP.2021.22.8.2391

Ejemplares similares